Foundation for Research in Liver Diseases

Analytics: Prof. W. Thormann
Home
About us
Liver diseases
Examinations
Prevention
Research
Cancer and angiogenesis
Drugs and antioxidants
Novel treatments
Copper
Alcohol
Analytics
 
 
 

We develop new techniques for analysis of drug levels and novel measurements to detect liver disease. Our main working horse is capillary electrophoresis.

Drugs and their metabolites are measured in body fluids such as blood or urine. These measurement are helpful to physicians to optimize use of drugs, i.e. to determine the right dose for an individual patient. Some measurements are also helpful in management of intoxication or to assess liver function. In drug development, measurements of drug levels are essential to our understanding of how the body metabolizes and eliminates a given drug. Detection of drugs of abuse or their consequences aare important in helping patients with alcohol or drug addiction.

Therefore, we are also interested in measuring markers of alcohol abuse such as carbohydrate deficient transferrin (CDT) or ethylglucuronide. Such measurements can give an indication of the extent and duration of substance abuse.

Our specialty - where we make major R&D efforts, is capillary electrophoresis. This technique permits detection of drugs, their metabolites, exogenous substances or endogeneous substances of interest at very low concentrations in small samples of bodily fluids such as blood, urine, saliva etc. In our analyses we use a few nanoliters (that would a millionth of a drop). The probe is injected into a capillary whose inner diameter corresponds to a human hair. An electrical field separates the different substances in the probe and the resulting peaks are analyzed optically Feldes in einzelne Stoffe zerlegt. Arzneimittel und andere Stoffe werden nach erfolgter Trennung or even by mass-spectroscopy. This approach - besides its elegance - has many practical advantages over older methods:

  • Very small samples can be analyed (not a drop - think about the children - no more needles - just a little spit
  • The capillaries are cheap
  • Much less or no use of volatile organic compounds - the environment greets thankfully

pdf about measurement of an important antiviral drug, ribavirin
pdf about measuring CDT

 
Stiftung für
Leberkrankheiten
Institut für Klinische Pharmakologie
Universität Bern

Murtenstrasse 35,
Postfach 49
3010 Bern
0041 (0)31 632 31 91
Info@leberstiftung.ch